Fructose transport-deficient Staphylococcus aureus reveals important role of epithelial glucose transporters in limiting sugar-driven bacterial growth in airway surface liquid

Abstract

Hyperglycaemia as a result of diabetes mellitus or acute illness is associated with increased susceptibility to respiratory infection with Staphylococcus aureus. Hyperglycaemia increases the concentration of glucose in airway surface liquid (ASL) and promotes the growth of S. aureus in vitro and in vivo. Whether elevation of other sugars in the blood, such as fructose, also results in increased concentrations in ASL is unknown and whether sugars in ASL are directly utilised by S. aureus for growth has not been investigated. We obtained mutant S. aureus JE2 strains with transposon disrupted sugar transport genes. NE768(fruA) exhibited restricted growth in 10 mM fructose. In H441 airway epithelial-bacterial co-culture, elevation of basolateral sugar concentration (5–20 mM) increased the apical growth of JE2. However, sugar-induced growth of NE768(fruA) was significantly less when basolateral fructose rather than glucose was elevated. This is the first experimental evidence to show that S. aureus directly utilises sugars present in the ASL for growth. Interestingly, JE2 growth was promoted less by glucose than fructose. Net transepithelial flux of d-glucose was lower than d-fructose. However, uptake of d-glucose was higher than d-fructose across both apical and basolateral membranes consistent with the presence of GLUT1/10 in the airway epithelium. Therefore, we propose that the preferential uptake of glucose (compared to fructose) limits its accumulation in ASL. Pre-treatment with metformin increased transepithelial resistance and reduced the sugar-dependent growth of S. aureus. Thus, epithelial paracellular permeability and glucose transport mechanisms are vital to maintain low glucose concentration in ASL and limit bacterial nutrient sources as a defence against infection.Electronic supplementary materialThe online version of this article (doi:10.1007/s00018-014-1635-y) contains supplementary material, which is available to authorized users.

Characterization of a Novel Two-Component Regulatory System, HptRS, the Regulator for the Hexose Phosphate Transport System in Staphylococcus aureus

“…In agreement with our findings, previous studies demonstrated that a high risk of S. aureus respiratory infection is correlated with an increased glucose concentration in blood and airway spaces (41). Another recent study demonstrated that S. aureus, upon internalization in A549 cells, highly increased transcription of transporters of inorganic ions, nucleotides, and carbohydrates, including UhpT (42).…”

A novel fluorescent sensor protein for detecting changes in airway surface liquid glucose concentration

“…Airway epithelial monolayers maintained their transepithelial resistance when glucose in the basolateral chamber was replaced with fructose, as previously reported [22]. As fructose did not bind to GBP–BADAN, ASL from cells grown in basolateral fructose was used to obtain ASL in which glucose was not present and correct for background fluorescence.…”

Dapagliflozin‐lowered blood glucose reduces respiratory Pseudomonas aeruginosa infection in diabetic mice

“…We propose that dapagliflozin exerts its anti‐infective effect by restricting glucose availability for P. aeruginosa growth/survival in the lung through a reduction in blood and ASL glucose concentrations. In support of this, genetic impairment of sugar transport pathways in P. aeruginosa and S. aureus that limited sugar uptake had a similar effect on bacterial growth/survival in the lung to that of dapagliflozin (Pezzulo et al, ; Garnett et al, ; Gill et al, ). Reduction of airway glucose in the distal mouse lung by manipulation of glucose transport pathways also reduced bacterial load (Oliveira et al, ).…”